1.63
price down icon5.23%   -0.09
after-market After Hours: 1.64 0.01 +0.61%
loading

Immix Biopharma Inc Stock (IMMX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
3.99%
5.5901
5.3759 4.5238 3.7207 2.5208
Operating Income/Loss
3.99%
-5.5901
-5.3759 -4.5238 -3.7207 -2.5208
Nonoperating Income/Loss
0.2679
- - 0.1288 0.0279
Income/Loss From Continuing Operations Before Tax
3.40%
-5.3222
-5.1473 -4.3371 -3.5919 -2.4929
Income Tax Expense/Benefit
9.27%
0.00884
0.00809 0.00681 0.00635 0.00517
Income/Loss From Continuing Operations After Tax
3.41%
-5.3311
-5.1554 -4.3439 -3.5982 -2.498
Net Income/Loss
3.41%
-5.3311
-5.1554 -4.3439 -3.5982 -2.498
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
9.43%
-0.0721
-0.0659 -0.0632 - -
Basic Average Shares
1,484%
23.44
1.48 18.58 15.04 13.90
Diluted Average Shares
1,484%
23.44
1.48 18.58 15.04 -0.5706
Basic Earnings Per Share
8.33%
-0.22
-0.24 -0.23 -0.24 -0.18
Diluted Earnings Per Share
8.33%
-0.22
-0.24 -0.23 -0.24 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):